Robert Weisskoff
Senior Partner·F-Prime
Bio
Professional summary
Robert Weisskoff is a Senior Partner at F-Prime, where he joined in 2004 after senior R&D and business development roles in pharmaceutical and medical device companies. He previously held academic roles at Harvard Medical School, the Harvard-MIT Health Sciences Technology Program, and Massachusetts General Hospital’s MGH-NMR Center. He serves on boards including Adela, Affinia Therapeutics, Countable Labs, Plasmagen Biosciences, RareCyte, Shinobi Therapeutics, and Zenflow.
Notable companies
Selected portfolio companies the partner has backed
Background
Career, education, and skills
Career history
- F-Prime CapitalSenior Partner2004 – Present
- Pharmaceutical and Medical Device CompaniesSenior R&D and Business Development Roles
- Harvard Medical SchoolAssociate Professor of Radiology
- Harvard-MIT Health Sciences Technology ProgramFaculty Member
- Massachusetts General HospitalAssociate Director, MGH-NMR Center
Education
- Columbia UniversityMBA
- Massachusetts Institute of TechnologyPhD in Physics
- Harvard UniversityAB in Physics
Other partners at F-Prime
12 more profiles
Abdul Abdirahman
Principal
F-Prime
Principal investing in early-stage B2B software, fintech, and vertical SaaS.
Alex Pasteur
Partner
F-Prime
Alex Pasteur is a London-based Partner at F-Prime Capital focused on therapeutics and life sciences.
Anastasiya Sybirna, PhD
Senior Associate
F-Prime
Senior Associate on F-Prime's London healthcare investment team.
Bala Varadhan
Principal
F-Prime
Principal focused on early-stage crypto, blockchain and Web3 investments.
Benjamin Gorman
Principal
F-Prime
Principal investing in early-stage enterprise software and AI.
Betsy Mulé
Principal
F-Prime
Principal investing in enterprise technology and robotics.
Brett Cook
Partner
F-Prime
F-Prime Partner investing in healthcare technology and services companies.
Brian Yordy
Principal
F-Prime
Principal investing in biopharmaceutical and medical technology companies.
Carl Bradford Byers 🚑
Partner
F-Prime
F-Prime Partner and former athenahealth founding CFO investing in healthcare IT and digital health.
Carl Byers
Partner
F-Prime
Carl Byers is a Partner at F-Prime Capital with significant operating experience in healthcare IT, including as a founding team member and CFO of athenahealth.
Chance Mathisen
Associate
F-Prime
Associate focused on early-stage enterprise software investments.
Chong Xu
Partner
F-Prime
F-Prime partner focused on biopharma, medtech, company formation, and China healthcare opportunities.